Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 3,3',5-triiodothyroacetic Acid N,n-diethanolamine (1:1) Complex
1. 1052-92-2
2. 3,3',5-triiodothyroacetic Acid N,n-diethanolamine (1:1) Complex
3. 3,3',5-tri-iodothyroacetic Acid, N-diethanolamine
4. Nsc 90775
5. Triiodothyroacetic Acid, Diethanolamine
6. Diethanolamine Salt Of Triiodothyroacetic Acid
7. (4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl)acetic Acid Diethanolamine Salt
8. Acetic Acid, (4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl)-, Compd. With 2,2'-iminodiethanol
9. Dtxsid20147002
10. Nsc90775
11. Nsc-90775
12. Acetic Acid, (4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl)-, Diethanolamine Salt
13. 4-(4-hydroxy-3-iodophenoxy)-3,5-diiodobenzeneacetic Acid, Compd. With 2,2'-iminobis(ethanol) (1:1)
14. Acetic Acid, (4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl)-, Compd. With 2,2'-iminodiethanol (1:1)
15. Benzeneacetic Acid, 4-(4-hydroxy-3-iodophenoxy)-3,5-diiodo-, Compd. With 2,2'-iminobis(ethanol) (1:1)
16. 3,5-tri-iodothyroacetic Acid, N-diethanolamine
17. Acetic Acid,5-diiodophenyl]-, Compd. With 2,2'-iminodiethanol (1:1)
18. Benzeneacetic Acid,5-diiodo-, Compd. With 2,2'-iminobis[ethanol] (1:1)
| Molecular Weight | 727.1 g/mol |
|---|---|
| Molecular Formula | C18H20I3NO6 |
| Hydrogen Bond Donor Count | 5 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 8 |
| Exact Mass | 726.8425 g/mol |
| Monoisotopic Mass | 726.8425 g/mol |
| Topological Polar Surface Area | 119 Ų |
| Heavy Atom Count | 28 |
| Formal Charge | 0 |
| Complexity | 385 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
ABOUT THIS PAGE
A Diethanolamine Triiodothyroacetate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Diethanolamine Triiodothyroacetate, including repackagers and relabelers. The FDA regulates Diethanolamine Triiodothyroacetate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Diethanolamine Triiodothyroacetate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Diethanolamine Triiodothyroacetate supplier is an individual or a company that provides Diethanolamine Triiodothyroacetate active pharmaceutical ingredient (API) or Diethanolamine Triiodothyroacetate finished formulations upon request. The Diethanolamine Triiodothyroacetate suppliers may include Diethanolamine Triiodothyroacetate API manufacturers, exporters, distributors and traders.
click here to find a list of Diethanolamine Triiodothyroacetate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Diethanolamine Triiodothyroacetate DMF (Drug Master File) is a document detailing the whole manufacturing process of Diethanolamine Triiodothyroacetate active pharmaceutical ingredient (API) in detail. Different forms of Diethanolamine Triiodothyroacetate DMFs exist exist since differing nations have different regulations, such as Diethanolamine Triiodothyroacetate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Diethanolamine Triiodothyroacetate DMF submitted to regulatory agencies in the US is known as a USDMF. Diethanolamine Triiodothyroacetate USDMF includes data on Diethanolamine Triiodothyroacetate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Diethanolamine Triiodothyroacetate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Diethanolamine Triiodothyroacetate suppliers with USDMF on PharmaCompass.
Diethanolamine Triiodothyroacetate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Diethanolamine Triiodothyroacetate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Diethanolamine Triiodothyroacetate GMP manufacturer or Diethanolamine Triiodothyroacetate GMP API supplier for your needs.
A Diethanolamine Triiodothyroacetate CoA (Certificate of Analysis) is a formal document that attests to Diethanolamine Triiodothyroacetate's compliance with Diethanolamine Triiodothyroacetate specifications and serves as a tool for batch-level quality control.
Diethanolamine Triiodothyroacetate CoA mostly includes findings from lab analyses of a specific batch. For each Diethanolamine Triiodothyroacetate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Diethanolamine Triiodothyroacetate may be tested according to a variety of international standards, such as European Pharmacopoeia (Diethanolamine Triiodothyroacetate EP), Diethanolamine Triiodothyroacetate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Diethanolamine Triiodothyroacetate USP).
LOOKING FOR A SUPPLIER?
